References
- Schmader K, George LK, Burchett BM, et al. Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 1998; 178 Suppl 1: S67-70
- Liesegang TJ. Varicella zoster viral disease. Mayo Clin Proc 1999; 74(10): 983-98
- Watson CP. Postherpetic neuralgia: the importance of preventing this intractable end-stage disorder. J Infect Dis 1998; 178 Suppl 1: S91-4
- Balfour HH Jr. Antiviral drugs. N Engl J Med 1999; 340(16): 1255-66
- Snoeck R, Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections. Drugs 1999; 57(2): 187-206
- Ladhani S, Williams HC. The management of established post-herpetic neuralgia: a comparison of the quality and content of traditional vs systematic reviews. Br J Dermatol 1998; 139(1): 66-72
- White CJ. Varicella-zoster virus vaccine. Clin Infect Dis 1997; 24(5): 753-63